 Clinical flow cytometry characteristics malignant pleural effusions patients intracavitary administration methylprednisolone acetate patients recurrent pleural effusions due advanced cancer intracavitary methylprednisolone acetate Depo-Medrol DM Upjohn Kalamazoo MI courses DM median courses patient doses mg course Effusion cells DM installation subsequent determination ploidy flow cytometry Pleural effusion patients advanced breast cancer follow-up months Pleural effusion patient metastatic gastric cancer patients adenocarcinoma unknown origin ten patients therapy patients treatment local systemic side effects Flow cytometry reduction ploidy effusion cells patients breast cancer peak mean channel therapy Transient reduction ploidy effusion patient unknown primary tumor clinical improvement clinical laboratory data offers initial evidence DM pleural cavity incomplete thoracentesis effective palliative therapy combination anticancer agents